Quintrio
Home

PHARMACEUTICAL PREPARATIONS

Aspire-Lakewood Holdings, Inc. Common Stock

ASBP

Aspire-Lakewood Holdings Inc is a United States-based company. Along with its subsidiary, it is involved in the design and manufacture of engineered automotive and industrial control systems that combine mechanical engineering, electronics, and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a powertrain-agnostic product portfolio that includes mechatronic actuators, human-machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates around 11 manufacturing facilities globally and serves as a tier-one automotive supplier to OEMs and other industrial firms.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $7.66 – $8.21
Volume 15,090
Market cap $11M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$11.3M
Price / earnings
—
Price / book
0.96×
Price / sales
115.76×
EV / sales
-8.83×
EV / EBITDA
0.12×

Profitability

Earnings per share
-$7.88
Return on assets
-81.6%
Return on equity
-93.97%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
7.99×
Quick ratio
7.81×
Cash ratio
7.22×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$7.19M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for ASBP, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025
Revenue$63.1K$28.35K$4.26K$1.94K$0$0
Cost of revenue$50.82K$22.6K$5.26K$1.06K$0$0
Gross profit$12.29K$5.75K-$1K$884$0$0
Selling, general and administrative$2.19M$1.36M$1.75M$938.48K$447K$15.29M
Research and development$233.48K$296.72K$100.04K$207.9K$352.89K$263.09K
Total operating expenses$2.69M$1.65M$1.85M$1.15M$799.89K$15.56M
Operating income-$2.68M-$1.65M-$1.85M-$1.15M-$799.89K-$15.56M
Interest expense$0-$1.6M-$6.23M-$1.48M-$527.89K-$289.93K
Income before taxes-$1.27M-$3.22M-$4.71M-$1.85M-$1.98M-$15.94M
Income taxes$0$0$0$0$0$0
Net income-$1.27M-$3.22M-$4.71M-$1.85M-$1.98M-$15.94M
Net income attributable to common shareholders-$1.27M-$3.22M-$4.71M-$1.85M-$1.98M-$15.94M
EBITDA-$2.41M-$1.65M-$1.85M-$1.15M-$799.89K-$15.56M
Basic earnings per share-$1.22-$20.57-$55.15-$48.00-$48.19-$504.88
Diluted earnings per share-$1.22-$20.57-$55.15-$48.00-$48.19-$504.88

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th

Aspire Biopharma Holdings (ASBP) announced it will present live at the Life Sciences Investor Forum on June 25th, 2026. The company highlighted its multiple prescription applications in cardiovascular and other therapeutic areas, its lead drug candidate high-dose aspirin product, and the commercial launch of BUZZ BOMB caffeine product. Aspire also announced a proposed acquisition of Dura Driver Control Systems, expected to close in Q3 2026.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Jul 14, 2005$192.00Jul 29, 2005unknown
Apr 13, 2005$180.00Apr 29, 2005unknown
Jan 12, 2005$180.00Jan 28, 2005unknown
Oct 13, 2004$180.00Oct 29, 2004unknown
Jul 14, 2004$180.00Jul 30, 2004unknown

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
May 11, 20261-for-30reverse split
Jan 16, 20261-for-40reverse split